M.-C. Pujazon

543 total citations
22 papers, 392 citations indexed

About

M.-C. Pujazon is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, M.-C. Pujazon has authored 22 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 7 papers in Immunology and Allergy. Recurrent topics in M.-C. Pujazon's work include Allergic Rhinitis and Sensitization (7 papers), Asthma and respiratory diseases (5 papers) and Occupational exposure and asthma (5 papers). M.-C. Pujazon is often cited by papers focused on Allergic Rhinitis and Sensitization (7 papers), Asthma and respiratory diseases (5 papers) and Occupational exposure and asthma (5 papers). M.-C. Pujazon collaborates with scholars based in France, Belgium and Switzerland. M.-C. Pujazon's co-authors include Pierre Carlès, D. Lauque, Françoise Laval, Gilbert J. Fournié, Jean-Jacques Chalé, Jacques P. Pourrat, Ulrich Wahn, J. de Blic, A. Didier and Michel Fournier and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Cancer Letters.

In The Last Decade

M.-C. Pujazon

19 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.-C. Pujazon France 9 171 110 109 102 86 22 392
Ryuji Nakano Japan 10 155 0.9× 139 1.3× 48 0.4× 131 1.3× 14 0.2× 26 363
A. M. Patterson United Kingdom 6 63 0.4× 52 0.5× 101 0.9× 94 0.9× 43 0.5× 6 389
Irene Grimani Greece 8 65 0.4× 167 1.5× 83 0.8× 44 0.4× 26 0.3× 11 363
Natalie Pui Ha Chan Hong Kong 9 69 0.4× 68 0.6× 39 0.4× 103 1.0× 17 0.2× 21 475
Paweł Basta Poland 15 39 0.2× 107 1.0× 39 0.4× 72 0.7× 14 0.2× 49 544
Walter Quan United States 10 85 0.5× 248 2.3× 100 0.9× 60 0.6× 18 0.2× 37 409
Xueju Wang China 11 44 0.3× 89 0.8× 56 0.5× 90 0.9× 7 0.1× 46 365
R. Schlenk Germany 10 40 0.2× 96 0.9× 31 0.3× 183 1.8× 17 0.2× 20 629
Mariel Maldonado Mexico 8 65 0.4× 52 0.5× 291 2.7× 101 1.0× 55 0.6× 16 441
Anne M. Sproul United Kingdom 11 54 0.3× 98 0.9× 22 0.2× 103 1.0× 18 0.2× 20 531

Countries citing papers authored by M.-C. Pujazon

Since Specialization
Citations

This map shows the geographic impact of M.-C. Pujazon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.-C. Pujazon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.-C. Pujazon more than expected).

Fields of papers citing papers by M.-C. Pujazon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.-C. Pujazon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.-C. Pujazon. The network helps show where M.-C. Pujazon may publish in the future.

Co-authorship network of co-authors of M.-C. Pujazon

This figure shows the co-authorship network connecting the top 25 collaborators of M.-C. Pujazon. A scholar is included among the top collaborators of M.-C. Pujazon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.-C. Pujazon. M.-C. Pujazon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prévôt, Grégoire, François Lintz, Jacques Aubry, et al.. (2025). Epidemiological disparities in pulmonary sarcoidosis between public and private healthcare sectors in haute-Garonne department (France). Respiratory Medicine and Research. 88. 101177–101177. 1 indexed citations
2.
Deshayes, Samuel, Nicolas Martin Silva, Delphine Mariotte, et al.. (2020). Prevalence of Anti-Neutrophil Cytoplasmic Antibodies and Associated Vasculitis in COPD Associated With Alpha-1 Antitrypsin Deficiency. CHEST Journal. 158(5). 1919–1922. 8 indexed citations
3.
4.
5.
Gauvain, Clément, Jean‐François Mornex, Christophe Pison, et al.. (2015). Health-Related Quality of Life in Patients with Alpha-1 Antitrypsin Deficiency: The French Experience. COPD Journal of Chronic Obstructive Pulmonary Disease. 12(sup1). 46–51. 14 indexed citations
6.
Thabut, Gabriel, Jean‐François Mornex, A. Cuvelier, et al.. (2015). Déclin du VEMS des emphysémateux déficitaires en alpha-1 antitrysine. Revue des Maladies Respiratoires. 33. A18–A19.
7.
Thabut, Gabriel, Christophe Pison, A. Cuvelier, et al.. (2014). Performance of the BODE index in patients with α1-antitrypsin deficiency-related COPD. European Respiratory Journal. 44(1). 78–86. 9 indexed citations
8.
Mornex, Jean‐François, Malika Balduyck, A. Cuvelier, et al.. (2014). Évaluation des pratiques de prescription du dosage pondéral de l’alpha-1 antitrypsine. Revue des Maladies Respiratoires. 31. A71–A72. 2 indexed citations
9.
Traclet, Julie, P. Camus, M.-C. Pujazon, & Jean‐François Mornex. (2013). Traitement substitutif prolongé du déficit en alpha-1 antitrypsine. Revue des Maladies Respiratoires. 30. A133–A134. 1 indexed citations
10.
Ameille, J., A. Didier, É. Serrano, et al.. (2011). Recommandations pour la prévention et la prise en charge de la rhinite allergique professionnelle. Revue des Maladies Respiratoires. 28(7). 940–949. 4 indexed citations
11.
Ameille, J., A. Didier, É. Serrano, et al.. (2011). Recommandations pour la prévention et la prise en charge de la rhinite allergique professionnelle. Archives des maladies professionnelles et de médecine du travail/Archives des maladies professionnelles et de l'environnement. 72(6). 613–622. 1 indexed citations
12.
Didier, A., M.-C. Pujazon, & C. Mailhol. (2010). Les outils diagnostiques de la rhinite professionnelle. Archives des maladies professionnelles et de médecine du travail/Archives des maladies professionnelles et de l'environnement. 71(3). 470–473. 4 indexed citations
13.
Migueres, Marion, et al.. (2009). Profils de sensibilisation cutanée aux pneumallergènes des patients consultant pour allergie respiratoire. Revue des Maladies Respiratoires. 26(5). 514–520. 13 indexed citations
14.
Pujazon, M.-C. & Pierre Carlès. (2008). Traitement substitutif par alpha-1 antitrypsine : suivi sur 20 ans d’un patient déficitaire. Revue des Maladies Respiratoires. 25(9). 1136–1141. 2 indexed citations
15.
Blic, J. de, et al.. (2005). Levocetirizine in children: evidenced efficacy and safety in a 6‐week randomized seasonal allergic rhinitis trial. Pediatric Allergy and Immunology. 16(3). 267–275. 69 indexed citations
16.
Lauque, D., et al.. (2002). Diffuse Infiltrative Lung Disease Associated with Flecainide. Respiration. 69(2). 182–185. 13 indexed citations
17.
Devys, Anne, Michel Simon, Gilles Salama, et al.. (2001). High Levels of Cytokeratin 19 Fragments But No Evidence of Cytokeratins 1, 2, 10/11, 14 or Filaggrin in the Serum of Squamous Cell Lung Carcinoma Patients. Tumor Biology. 22(1). 19–26. 9 indexed citations
18.
Pujazon, M.-C., et al.. (1999). [Respiratory complications of the vinorelbine-mitomycin combination].. PubMed. 16(1). 81–4. 2 indexed citations
19.
Fournié, Gilbert J., Françoise Laval, Jean-Jacques Chalé, et al.. (1995). Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Letters. 91(2). 221–227. 221 indexed citations
20.
Constans, J., Pierre Carlès, A Boneu, et al.. (1992). Clinical Pharmacokinetics of α1-Antitrypsin in Homozygous PiZ Deficient Patients. Clinical Pharmacokinetics. 23(2). 161–168. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryuji Nakano Breakdown of academic impact, for papers by A. M. Patterson Breakdown of academic impact, for papers by Irene Grimani Breakdown of academic impact, for papers by Natalie Pui Ha Chan Breakdown of academic impact, for papers by Paweł Basta Breakdown of academic impact, for papers by Walter Quan Breakdown of academic impact, for papers by Xueju Wang Breakdown of academic impact, for papers by R. Schlenk Breakdown of academic impact, for papers by Mariel Maldonado Breakdown of academic impact, for papers by Anne M. Sproul
Rankless by CCL
2026